The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance

Documenti analoghi

• Dolutegravir Resistance Mutation R263K Cannot Coexist in Combination with Many Classical Integrase Inhibitor Resistance Substitutions
  di: Anstett, Kaitlin, et al.
  Pubblicazione: (2015)
• Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity
  di: Anstett, Kaitlin, et al.
  Pubblicazione: (2015)
• The R262K Substitution Combined with H51Y in HIV-1 Subtype B Integrase Confers Low-Level Resistance against Dolutegravir
  di: Cutillas, Vincent, et al.
  Pubblicazione: (2014)
• Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
  di: Quashie, Peter K., et al.
  Pubblicazione: (2012)
• The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
  di: Wainberg, Mark, et al.
  Pubblicazione: (2014)